We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
Turnover
16.91%
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+0.6%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$4.18M
(-3.5%)
Cap. Flow
-$1.91M
Cap. Flow
% of AUM
-1.68%
Top 10 Holdings %
Top 10 Hldgs %
30.55%
Holding
133
New
11
Increased
32
Reduced
60
Closed
9
Avg Time Held Equity + Options
1.8
years
Top 10 Avg Time Held Equity + Options
0.8
years
Top 20 Avg Time Held Equity + Options
1.4
years
Avg Time Held Equity only
1.8
years
Top 10 Avg Time Held Equity only
0.8
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprott Physical Gold
PHYS
|
+$1.92M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$820K |
| 3 |
BlackRock Core Bond Trust
BHK
|
+$792K |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$767K |
| 5 |
CLNY
Colony Capital, Inc.
CLNY
|
+$546K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$3.5M |
| 2 |
Apple
AAPL
|
+$2.53M |
| 3 |
Alibaba
BABA
|
+$1.63M |
| 4 |
Realty Income
O
|
+$1.24M |
| 5 |
Microsoft
MSFT
|
+$666K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.07% |
| 2 | Real Estate | 17.82% |
| 3 | Healthcare | 11.94% |
| 4 | Technology | 11.86% |
| 5 | Financials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
MetLife Inc Floating Rate Series A
MET.PRA
$507M
| $626K | 0.55% |
25,100
-2,200
| -8% | -$54.1K |
2013 Q2
11 quarters
|
|
|
AERI
52
DELISTED
Aerie Pharmaceuticals
AERI
| $614K | 0.54% |
50,500
-5,300
| -9% | -$83.9K |
2014 Q3
6 quarters
|
|
53
iShares Mortgage Real Estate ETF
REM
$460M
| $607K | 0.53% |
15,700
-875
| -5% | -$32.2K |
2013 Q2
11 quarters
|
|
|
FALC
54
DELISTED
FalconStor Software Inc
FALC
| $579K | 0.51% |
432,100
| – | – |
2013 Q2
11 quarters
|
|
55
Safehold
SAFE
$818M
| $570K | 0.5% |
12,131
-637
| -5% | -$29.3K |
2013 Q2
11 quarters
|
|
56
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.16B
| $562K | 0.49% |
16,149
-1,300
| -7% | -$40.6K |
2014 Q1
8 quarters
|
|
57
Sanofi
SNY
$96.5B
| $554K | 0.49% |
13,800
-250
| -2% | -$10K |
2015 Q1
4 quarters
|
|
58
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
| $536K | 0.47% |
37,989
-1,228
| -3% | -$16.5K |
2014 Q4
5 quarters
|
|
59
Morgan Stanley Series A Preferred Stock
MS.PRA
$762M
| $513K | 0.45% |
25,305
-1,700
| -6% | -$34K |
2013 Q2
11 quarters
|
|
60
Capital Clean Energy Carriers
CCEC
$1.22B
| $498K | 0.44% |
22,509
-200
| -0.9% | -$5.05K |
2013 Q2
11 quarters
|
|
61
DELISTED
Spectra Energy Corp Wi
SE
| $485K | 0.43% |
15,850
-550
| -3% | -$15.5K |
2015 Q3
2 quarters
|
|
62
BlackRock MuniHoldings California Quality Fund
MUC
$1.21B
| $484K | 0.42% |
30,700
+6,500
| +27% | +$99K |
2013 Q2
11 quarters
|
|
|
BNBX
63
DELISTED
BNB PLUS CORP
BNBX
| – | – |
0
| – | – |
2015 Q2
3 quarters
|
|
|
MCR
64
DELISTED
MFS Charter Income Trust
MCR
| $461K | 0.4% |
56,650
-5,000
| -8% | -$39K |
2013 Q2
11 quarters
|
|
65
Ally Financial
ALLY
$11.5B
| $431K | 0.38% |
23,000
+10,500
| +84% | +$181K |
2015 Q3
2 quarters
|
|
66
MGM Resorts International
MGM
$7.42B
| $429K | 0.38% |
+20,000
| New | +$395K |
2016 Q1
0 quarters
|
|
67
DELISTED
Real Industry, Inc.
RELY
| $413K | 0.36% |
47,500
-6,500
| -12% | -$44.6K |
2015 Q2
3 quarters
|
|
68
American International
AIG
$41.4B
| $405K | 0.36% |
7,500
-3,500
| -32% | -$189K |
2013 Q2
11 quarters
|
|
69
Royal Gold
RGLD
$19.7B
| $374K | 0.33% |
7,300
| – | – |
2013 Q4
9 quarters
|
|
70
Kinder Morgan
KMI
$73.1B
| $360K | 0.32% |
20,150
-3,800
| -16% | -$62.2K |
2015 Q4
1 quarter
|
|
71
Walt Disney
DIS
$191B
| $358K | 0.31% |
3,600
| – | – |
2013 Q2
11 quarters
|
|
72
Vanguard Real Estate ETF
VNQ
$36.7B
| $356K | 0.31% |
4,250
-750
| -15% | -$58.4K |
2013 Q4
9 quarters
|
|
73
Colgate-Palmolive
CL
$73.9B
| $353K | 0.31% |
5,000
| – | – |
2013 Q2
11 quarters
|
|
74
Global Ship Lease
GSL
$1.51B
| $345K | 0.3% |
37,488
-1,000
| -3% | -$13.3K |
2014 Q4
5 quarters
|
|
75
Abundia Global Impact Group
AGIG
$37.5M
| $344K | 0.3% |
13,099
-152
| -1% | -$3.48K |
2013 Q2
11 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Benchmark Capital Advisors held 133 positions worth $114M, down 3.5% from $118M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Benchmark Capital Advisors's Q1 2016 filing shows 11 new, 32 increased, 60 reduced and 9 closed positions. Its largest new stake was Teva Pharmaceutical Industries Limited: 13,975 shares worth $748K. The largest sale was GE Aerospace, an estimated $3.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, up from 14% a quarter earlier, followed by Real Estate and Healthcare.
- Benchmark Capital Advisors's largest Q1 2016 buy was Teva Pharmaceutical Industries Limited: 13,975 shares worth $748K.
- Benchmark Capital Advisors added most to Sprott Physical Gold in Q1 2016, an estimated $1.92M increase.
- Benchmark Capital Advisors's biggest Q1 2016 reduction was GE Aerospace, cutting an estimated $3.5M.
- Benchmark Capital Advisors fully exited Alibaba in Q1 2016, selling an estimated $1.63M.
- Benchmark Capital Advisors's ten largest holdings make up 31% of its $114M portfolio in Q1 2016.
- Benchmark Capital Advisors opened 11 new positions and closed 9 in Q1 2016.
- Benchmark Capital Advisors's portfolio value fell 3.5% quarter-over-quarter to $114M.
Based on Benchmark Capital Advisors's 13F filing for Q1 2016, filed 10 May 2016.